Evidence for the homeostatic regulation of induced beta cell mass expansion

Diabetologia

Volumn 49, Issue 12, 2006, Pages 2910-2919

  Lipsett, M A ^a,b   Austin, E B ^a,b   Castellarin, M L ^a,b   Lemay, J ^a,b   Rosenberg, L ^a,b  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

Beta cell mass; Beta cell neogenesis; Diabetes mellitus; Endogenous progenitor cell therapy; Islet neogenesis

Indexed keywords

GLUCOSE; ISLET NEOGENESIS ASSOCIATED PROTEIN 104 118; PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DIVISION; CELL GROWTH; CELL SIZE; CELL STIMULATION; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; NONHUMAN; PANCREAS DUCT STENOSIS; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; SPECIES COMPARISON; SYRIAN HAMSTER;

ANIMALS; APOPTOSIS; BLOOD GLUCOSE; CELL DIVISION; CELL SIZE; CRICETINAE; FEMALE; HOMEOSTASIS; INSULIN; INSULIN-SECRETING CELLS; MALE; MESOCRICETUS; PANCREATIC DUCTS;

EID: 33750908049     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-006-0428-8     Document Type: Article

References (50)

1. Hellerstrom C (1984) The life story of the pancreatic B cell. Diabetologia 26:393-400
2. Kloppel G, Lohr M, Habich K, Oberholzer M, Heitz PU (1985) Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited. Surv Synth Pathol Res 4:110-125
3. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC (2003) Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52:102-110
4. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986
5. UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853
6. Writing team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group (2003) Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy. JAMA 290:2159-2167
7. Shapiro AM, Lakey JR, Ryan EA et al (2000) Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 343:230-238
8. Ryan EA, Lakey JR, Rajotte RV et al (2001) Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes 50:710-719
9. Sutherland DE, Gruessner RW, Gruessner AC (2001) Pancreas transplantation for treatment of diabetes mellitus. World J Surg 25:487-496
10. Ault A (2003) Edmonton's islet success tough to duplicate elsewhere. Lancet 361:2054
11. Ryan EA, Paty BW, Senior PA et al (2005) Five-year follow-up after clinical islet transplantation. Diabetes 54:2060-2069
12. Suarez-Pinzon WL, Yan Y, Power R, Brand SJ, Rabinovitch A (2005) Combination therapy with epidermal growth factor and gastrin increases beta-cell mass and reverses hyperglycemia in diabetic NOD mice. Diabetes 54:2596-2601
13. Brand SJ, Tagerud S, Lambert P et al (2002) Pharmacological treatment of chronic diabetes by stimulating pancreatic beta-cell regeneration with systemic co-administration of EGF and gastrin. Pharmacol Toxicol 91:414-420
14. Rosenberg L, Lipsett M, Yoon JW et al (2004) A pentadecapeptide fragment of islet neogenesis-associated protein increases beta-cell mass and reverses diabetes in C57BL/6J mice. Ann Surg 240:875-884
15. Rooman I, Lardon J, Bouwens L (2002) Gastrin stimulates beta-cell neogenesis and increases islet mass from transdifferentiated but not from normal exocrine pancreas tissue. Diabetes 51:686-690
16. Lardon J, Bouwens L (2005) Metaplasia in the pancreas. Differentiation 73:278-286
17. Laidlaw GF (1938) Nesidioblastoma, the islet tumor of the pancreas. Am J Pathol 14:125-139
18. Pavelic K, Hrascan R, Kapitanovic S et al (1995) Multiple genetic alterations in malignant metastatic insulinomas. J Pathol 177:395-400
19. Wagner M, Luhrs H, Kloppel G, Adler G, Schmid RM (1998) Malignant transformation of duct-like cells originating from acini in transforming growth factor transgenic mice. Gastroenterology 115:1254-1262
20. Kinoshita Y, Ishihara S, Kadowaki Y, Fukui H, Chiba T (2004) Reg protein is a unique growth factor of gastric mucosal cells. J Gastroenterol 39:507-513
21. Parsons JA, Bartke A, Sorenson RL (1995) Number and size of islets of Langerhans in pregnant, human growth hormone-expressing transgenic, and pituitary dwarf mice: effect of lactogenic hormones. Endocrinology 136:2013-2021
22. Scaglia L, Smith FE, Bonner-Weir S (1995) Apoptosis contributes to the involution of beta cell mass in the post partum rat pancreas. Endocrinology 136:5461-5468
23. Silberstein GB (2001) Postnatal mammary gland morphogenesis. Microsc Res Tech 52:155-162
24. Strange R, Metcalfe T, Thackray L, Dang M (2001) Apoptosis in normal and neoplastic mammary gland development. Microsc Res Tech 52:171-181
25. Furth PA (1999) Introduction: mammary gland involution and apoptosis of mammary epithelial cells. J Mammary Gland Biol Neoplasia 4:123-127
26. Djonov V, Andres AC, Ziemiecki A (2001) Vascular remodelling during the normal and malignant life cycle of the mammary gland. Microsc Res Tech 52:182-189
27. Jerry DJ, Pinkas J, Kuperwasser C, Dickinson ES, Naber SP (1999) Regulation of p53 and its targets during involution of the mammary gland. J Mammary Gland Biol Neoplasia 4:177-181
28. Li M, Hu J, Heermeier K, Hennighausen L, Furth PA (1996) Apoptosis and remodeling of mammary gland tissue during involution proceeds through p53-independent pathways. Cell Growth Differ 7:13-20
29. Li M, Liu X, Robinson G et al (1997) Mammary-derived signals activate programmed cell death during the first stage of mammary gland involution. Proc Natl Acad Sci USA 94:3425-3430
30. Rosenberg L, Brown RA, Duguid WP (1983) A new approach to the induction of duct epithelial hyperplasia and nesidioblastosis by cellophane wrapping of the hamster pancreas. J Surg Res 35:63-72
31. Wang RN, Bouwens L, Kloppel G (1994) Beta-cell proliferation in normal and streptozotocin-treated newborn rats: site, dynamics and capacity. Diabetologia 37:1088-1096
32. Lipsett M, Finegood DT (2002) Beta-cell neogenesis during prolonged hyperglycemia in rats. Diabetes 51:1834-1841
33. Bouwens L, Pipeleers DG (1998) Extra-insular beta cells associated with ductules are frequent in adult human pancreas. Diabetologia 41:629-633
34. Steil GM, Trivedi N, Jonas JC et al (2001) Adaptation of beta-cell mass to substrate oversupply: enhanced function with normal gene expression. Am J Physiol Endocrinol Metab 280:E788-E796
35. Scaglia L, Cahill CJ, Finegood DT, Bonner-Weir S (1997) Apoptosis participates in the remodeling of the endocrine pancreas in the neonatal rat. Endocrinology 138:1736-1741
36. Finegood DT, Scaglia L, Bonner-Weir S (1995) Dynamics of beta-cell mass in the growing rat pancreas. Estimation with a simple mathematical model. Diabetes 44:249-256
37. Paris M, Bernard-Kargar C, Berthault MF, Bouwens L, Ktorza A (2003) Specific and combined effects of insulin and glucose on functional pancreatic beta-cell mass in vivo in adult rats. Endocrinology 144:2717-2727
38. Borelli MI, Stoppiglia LF, Rezende LF et al (2005) INGAP-related pentadecapeptide: its modulatory effect upon insulin secretion. Regul Pept 131:97-102
39. Watanabe T, Yonemura Y, Yonekura H et al (1994) Pancreatic beta-cell replication and amelioration of surgical diabetes by Reg protein. Proc Natl Acad Sci USA 91:3589-3592
40. Gross DJ, Weiss L, Reibstein I et al (1998) Amelioration of diabetes in nonobese diabetic mice with advanced disease by linomide-induced immunoregulation combined with Reg protein treatment. Endocrinology 139:2369-2374
41. Unno M, Nata K, Noguchi N et al (2002) Production and characterization of Reg knockout mice: reduced proliferation of pancreatic beta-cells in Reg knockout mice. Diabetes 51(Suppl 3):S478-S483
42. Okamoto H (1999) The Reg gene family and Reg proteins: with special attention to the regeneration of pancreatic beta-cells. J Hepatobiliary Pancreat Surg 6:254-262
43. Ashcroft FJ, Varro A, Dimaline R, Dockray GJ (2004) Control of expression of the lectin-like protein Reg-1 by gastrin: role of the Rho family GTPase RhoA and a C-rich promoter element. Biochem J 381:397-403
44. Meier JJ, Ritzel RA, Maedler K, Gurlo T, Butler PC (2006) Increased vulnerability of newly forming beta cells to cytokine-induced cell death. Diabetologia 49:83-89
45. Petropavlovskaia M, Makhlin J, Sampalis J, Rosenberg L (2006) Development of an in vitro pancreatic tissue model to study regulation of islet neogenesis associated protein (INGAP) expression. J Endocrinol (in press)
46. Lipsett M, Hanley S, Castellarin M et al (2006) The role of islet neogenesis-associated protein (INGAP) in islet neogenesis. Cell Biochem Biophys (in press)
47. Bonner-Weir S, Baxter LA, Schuppin GT, Smith FE (1993) A second pathway for regeneration of adult exocrine and endocrine pancreas. A possible recapitulation of embryonic development. Diabetes 42:1715-1720
48. Wang GS, Rosenberg L, Scott FW (2005) Tubular complexes as a source for islet neogenesis in the pancreas of diabetes-prone BB rats. Lab Invest 85:675-688
49. Gu D, Sarvetnick N (1993) Epithelial cell proliferation and islet neogenesis in IFN-g transgenic mice. Development 118:33-46
50. Meier JJ, Bhushan A, Butler AE, Rizza RA, Butler PC (2005) Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration? Diabetologia 48:2221-2228